Betel quid is a chewing preparation made from three core ingredients: areca nut, betel leaf, and slaked lime (calcium hydroxide). Known as “paan” or “pan” across South and Southeast Asia, it is one of the most widely used psychoactive substances in the world, with hundreds of millions of regular users concentrated in lower-middle-income countries. The International Agency for Research on Cancer classifies betel quid as a Group 1 carcinogen, the highest level, regardless of whether tobacco is added.
What Goes Into a Betel Quid
A traditional betel quid starts with a fresh betel leaf, which serves as a wrapper. Inside, the chewer places pieces of areca nut (often called “betel nut,” though it comes from an entirely different plant) and a smear of slaked lime paste. Many preparations also include tobacco. Beyond these basics, the recipe varies enormously by region. Cardamom, saffron, cloves, aniseed, turmeric, mustard, and sweeteners are all common additions depending on local taste.
Commercially processed versions also exist. Products like gutka and pan masala are factory-made, shelf-stable mixtures that package areca nut, slaked lime, spices, and sometimes tobacco into small foil sachets. These are widely sold across South Asia and have made areca nut consumption more convenient and accessible, particularly among younger users.
How It Works in the Body
The primary psychoactive compound in betel quid is arecoline, an alkaloid found in the areca nut. Arecoline mimics acetylcholine, a neurotransmitter involved in muscle movement, alertness, and mood. It activates the same receptor systems that nicotine does, stimulating both the central nervous system and the autonomic nervous system. The result is a feeling of well-being, increased alertness, and a sense of greater endurance.
Slaked lime plays a critical and often overlooked role. It isn’t just filler. When mixed with saliva during chewing, slaked lime raises the pH inside the mouth, converting the active alkaloids into a form that passes much more easily through the soft tissue lining the cheeks and gums. Without it, the body would absorb far less arecoline. This is the same basic principle behind other oral drug delivery systems: making a compound more alkaline helps it cross cell membranes faster. People have been exploiting this chemistry for centuries, long before anyone understood the mechanism.
Where It’s Most Common
Betel quid use is concentrated in South Asia, Southeast Asia, and the Pacific Islands. The regions with the highest rates of oral cancer linked to areca nut and smokeless tobacco are Melanesia, Micronesia, and Polynesia, where nearly 79% of oral cancers are attributable to these products. South-central Asia follows at about 58%, and Southeast Asia at roughly 20%.
A 2024 analysis published in The Lancet Oncology estimated that about 120,200 cases of oral cancer diagnosed in 2022 were attributable to smokeless tobacco or areca nut use, representing nearly a third of all oral cancers worldwide. About 77% of those cases were in men. Ninety percent occurred in lower-middle-income countries, where betel quid chewing is deeply embedded in social customs, religious rituals, and daily routines.
Why It Becomes Addictive
Regular betel quid use can lead to a recognized pattern of dependence. The process typically follows a familiar trajectory: social or cultural initiation, followed by habituation as the brain adapts to repeated arecoline exposure. Over time, users develop tolerance (needing more to feel the same effect), experience cravings, and eventually lose control over how much and how often they chew.
Chronic use causes the brain’s cholinergic system, the network of signaling pathways that arecoline activates, to recalibrate around the constant presence of the drug. When someone stops abruptly, that system is thrown off balance. Withdrawal symptoms include anxiety, restlessness, irritability, and difficulty concentrating. Clinicians can screen for dependence using a simple tool called the BETEL questionnaire, which asks about frequency of use, whether someone chews first thing in the morning, tolerance, and loss of control.
Oral Health Effects
The most distinctive oral consequence of long-term betel quid use is oral submucous fibrosis, a chronic scarring condition that affects the lining of the mouth, throat, and sometimes the upper esophagus. It is considered a precancerous condition, meaning it significantly raises the risk of developing oral cancer over time.
The disease develops gradually. Early signs include a burning sensation in the mouth, pain, and small ulcers on the inner cheeks or tongue. As fibrosis progresses, the oral lining turns pale and takes on a leathery texture. The tongue loses its normal surface texture and becomes smooth. In more advanced stages, the scarring restricts how far the jaw can open, making it increasingly difficult to eat or speak normally. Some people develop voice changes or even hearing problems when the fibrosis extends to the throat.
These changes are not cosmetic. Oral submucous fibrosis does not reliably reverse on its own, and in many cases the damage is permanent even after a person stops chewing.
Cancer Risk
The World Health Organization’s cancer research agency has classified betel quid with tobacco, betel quid without tobacco, and areca nut alone as Group 1 carcinogens. This is the same category as asbestos and cigarette smoking, meaning there is sufficient evidence that each causes cancer in humans.
Betel quid with tobacco causes cancers of the mouth, throat (pharynx), and esophagus. Betel quid without tobacco still causes oral cancer. The areca nut itself is carcinogenic regardless of what it’s combined with, largely because of its role in triggering oral submucous fibrosis and through the formation of cancer-promoting compounds called nitrosamines during chewing.
Cardiovascular and Metabolic Effects
The health risks extend well beyond the mouth. Systematic reviews have linked habitual betel quid chewing to hypertension, atherosclerosis (hardening of the arteries), chronic inflammation, and ischemic heart disease, the type caused by reduced blood flow to the heart. It also increases the risk of irregular heart rhythms. Long-term use is associated with higher all-cause mortality, meaning a greater chance of dying from any cause, not just cancer.
One notable finding is that betel quid use appears to be an independent cardiovascular risk factor for women, meaning it raises heart disease risk on its own, separate from other factors like smoking or obesity. In populations where chewing is widespread, it represents a significant and often underrecognized contributor to heart disease.